Clinical Trial Results:
A double-blind, placebo controlled, randomised, parallel group, single centre, phase IIa study to investigate the efficacy, tolerability and safety of 8 doses of
AZD8848 administered intranasally once weekly in mild to
moderate allergic asthma patients challenged with an inhaled allergen.
Summary
|
|
EudraCT number |
2009-013705-34 |
Trial protocol |
GB |
Global completion date |
01 Dec 2011
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
17 Jul 2016
|
First version publication date |
17 Jul 2016
|
Other versions |
|
Summary report(s) |
D0540C00004_results.pdf |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.